![James R. Piggott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in James R. Piggott first degree
Entity | Entity type | Industry | |
---|---|---|---|
ZymoGenetics, Inc.
![]() ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
8
| Extinct | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to James R. Piggott via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
aQuantive, Inc.
![]() aQuantive, Inc. Advertising/Marketing ServicesCommercial Services aQuantive, Inc. designs and develops digital marketing services and provides related online solutions. The company offers services such as online media buying and planning, ad campaign management, e-mail direct marketing, search engine optimization, and data warehousing and analysis. The company was founded in 1997 and is headquartered in Seattle, WA | Advertising/Marketing Services | General Counsel | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Executive Officer | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Thiakis Ltd.
![]() Thiakis Ltd. Pharmaceuticals: MajorHealth Technology Thiakis Ltd. develops hormone-based treatments for obesity and other metabolic diseases. It focuses to commercialize an effective anti-obesity treatment based on a peptide hormone called oxyntomodulin. The company was founded in 2004 by Steve Bloom and John Burt and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Corporate Officer/Principal | |
CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Director/Board Member | |
Novo Nordisk Fonden
![]() Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chairman | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | President Chairman | |
Ferring Pharmaceuticals A/S
![]() Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree | |
Ferring Holding SA
![]() Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Technical University of Denmark | College/University | Undergraduate Degree Graduate Degree | |
AGC Biologics A/S
![]() AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
ReNeuron Ltd.
![]() ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Scandinavian International Management Institute | College/University | Corporate Officer/Principal | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
The Bioindustry Association
![]() The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Vantia Ltd.
![]() Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ferring International Center SA
![]() Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Chairman | |
Tarsa Therapeutics, Inc.
![]() Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Royal College of General Practitioners
![]() Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Other Consumer Services | Corporate Officer/Principal | |
Epsilon-3 Bio Ltd
![]() Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Founder | |
Nuvelution Pharma, Inc.
![]() Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
Morphic Therapeutic, Inc.
![]() Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Essity Germany GmbH
![]() Essity Germany GmbH Household/Personal CareConsumer Non-Durables Part of Industrivärden AB, Essity Germany GmbH is the world's second largest supplier of consumer tissue, offering a range of products including toilet paper, kitchen rolls, facial tissues, handkerchiefs, and napkins. Essity Germany is based in Mannheim, DE, and Andreas Pier has been the CEO of the company since 2018. The German company provides practical advice for maintaining a clean and cozy home. | Household/Personal Care | Director/Board Member | |
MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novo Holdings A/S (Investment Company)
![]() Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Corporate Officer/Principal | |
HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
![]() Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
![]() Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
NANOFORM FINLAND OYJ | Biotechnology | Director/Board Member | |
Synklino ApS
![]() Synklino ApS Medical/Nursing ServicesHealth Services Synklino ApS is a Danish biotech company that focuses on developing innovative therapies against virus infections. The company's first-in-class drug candidate, Syn002, targets cytomegalovirus infection in transplantation patients and aims to change the current antiviral treatment paradigm. Synklino is owned by renowned Nordic funds and institutional investors, including Eir Ventures, the Danish Growth Fund, and PKA, as well as approximately 70 private shareholders. The company is a spinout from the University of Copenhagen and the Technical University of Denmark and is incubated at the BioInnovation Institute in its prestigious Creation House program. | Medical/Nursing Services | Director/Board Member | |
Bactolife A/S
![]() Bactolife A/S BiotechnologyHealth Technology Bactolife A/S is a Danish industrial biotech company that specializes in developing biological solutions to strengthen the gut microbiome and combat antimicrobial resistance. Bactolife is based in Kongens Lyngby, Denmark and was founded in 2017 by Andreas Hougaard Laustsen, Per Falholt, Mads Laustsen, David Kauffmann, and Sandra Wingaard Thrane. The company has approximately 40 employees and uses its proprietary binding protein technology to select and produce binding proteins that act on toxins without targeting growth or killing bacteria directly. Bactolife is developing and marketing ingredients for various groups, including mothers and children, the elderly, immunodeficient individuals, travelers, deployed individuals, and animal health. The company has proof of concept for its technology, including its most advanced animal health product, ablacto+, which stabilizes the gut of piglets and reduces the severity of post-weaning diarrhea. Mads Laustsen has been the CEO since 2017. | Biotechnology | Founder | |
Cmc Biologics A/S | Chief Executive Officer Corporate Officer/Principal | ||
Propel Bio Partners LLC
![]() Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | Investment Managers | Consultant / Advisor | |
VenomAid Diagnostics ApS
![]() VenomAid Diagnostics ApS Medical/Nursing ServicesHealth Services VenomAid Diagnostics ApS provides diagnostic test services for snake bites. The company is based in Kongens Lyngby, Denmark. The Danish company was founded by Cecilie Knudsen, Søren H. Dam, Jonas A. Jürgensen, Andreas Hougaard Laustsen. Jonas A. Jürgensen has been the CEO since incorporation. | Medical/Nursing Services | Director/Board Member |
Statistics
International
United States | 17 |
Denmark | 17 |
United Kingdom | 14 |
Switzerland | 4 |
Germany | 2 |
Sectoral
Health Technology | 31 |
Consumer Services | 7 |
Commercial Services | 4 |
Consumer Non-Durables | 4 |
Finance | 4 |
Operational
Director/Board Member | 68 |
Chairman | 23 |
Corporate Officer/Principal | 23 |
Independent Dir/Board Member | 19 |
Chief Executive Officer | 8 |
Most connected contacts
Insiders | |
---|---|
Martin Edwards | 38 |
Bruce Carter | 25 |
Lars Rebien Sørensen | 22 |
Kurt Anker Nielsen | 18 |
Mads Laustsen | 11 |
Suzanne M. Shema | 8 |
Darren R. Hamby | 5 |
Erik Laursen | 5 |
- Stock Market
- Insiders
- James R. Piggott
- Company connections